Inogen (INGN) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

INGN Stock Forecast

Inogen stock forecast is as follows: an average price target of $26.00 (represents a 182.30% upside from INGN’s last price of $9.21) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

INGN Price Target

The average price target for Inogen (INGN) is $26.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $26.00 to $26.00. This represents a potential 182.30% upside from INGN's last price of $9.21.

INGN Analyst Ratings

Buy

According to 2 Wall Street analysts, Inogen's rating consensus is 'Buy'. The analyst rating breakdown for INGN stock is 0 'Strong Buy' (0.00%), 1 'Buy' (50.00%), 1 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Inogen Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Jul 14, 2023	Mike Matson	Needham	$26.00	$8.82	194.78%	182.30%

Row per page

Go to

The latest Inogen stock forecast, released on Jul 14, 2023 by Mike Matson from Needham, set a price target of $26.00, which represents a 194.78% increase from the stock price at the time of the forecast ($8.82), and a 182.30% increase from INGN last price ($9.21).

Inogen Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	-
Avg Price Target	-	-	-
Last Closing Price	$9.21	$9.21	$9.21
Upside/Downside	-100.00%	-100.00%	-100.00%

In the current month, the average price target of Inogen stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Inogen's last price of $9.21. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Feb 15, 2024	William Blair	-	Outperform	Upgrade
Jul 14, 2023	Needham	-	Hold	Downgrade

Row per page

Go to

Inogen's last stock rating was published by William Blair on Feb 15, 2024. The company Upgrade its INGN rating from "null" to "Outperform".

Inogen Financial Forecast

Inogen Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$75.90M	$83.97M	$83.64M	$72.16M	$88.09M	$105.39M	$103.38M	$80.39M	$76.40M	$93.11M	$101.56M	$86.93M	$73.98M	$74.33M	$71.69M	$88.49M	$78.92M	$91.76M
Avg Forecast	$84.07M	$100.33M	$99.86M	$83.96M	$81.63M	$92.28M	$91.90M	$79.08M	$73.88M	$84.14M	$82.50M	$73.66M	$76.96M	$82.58M	$92.16M	$74.62M	$89.49M	$97.72M	$100.64M	$76.56M	$75.98M	$86.69M	$88.75M	$79.39M	$69.64M	$76.06M	$79.96M	$82.00M	$86.41M	$91.65M
High Forecast	$84.32M	$100.63M	$100.15M	$84.21M	$81.88M	$92.56M	$92.17M	$79.31M	$74.37M	$84.14M	$82.74M	$73.67M	$77.95M	$82.83M	$92.43M	$74.84M	$89.76M	$97.72M	$100.64M	$76.56M	$75.98M	$86.69M	$88.75M	$79.39M	$69.64M	$76.06M	$79.96M	$82.00M	$86.41M	$91.65M
Low Forecast	$83.85M	$100.07M	$99.59M	$83.74M	$81.42M	$92.04M	$91.66M	$78.87M	$73.48M	$84.14M	$82.28M	$73.66M	$75.97M	$82.34M	$91.92M	$74.42M	$89.26M	$97.72M	$100.64M	$76.56M	$75.98M	$86.69M	$88.75M	$79.39M	$69.64M	$76.06M	$79.96M	$82.00M	$86.41M	$91.65M
# Analysts	1	1	1	1	1	1	1	1	3	1	2	2	4	2	2	2	1	1	1	1	2	2	2	2	13	8	8	9	12	7
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.99%	1.02%	0.91%	0.97%	0.98%	1.08%	1.03%	1.05%	1.01%	1.07%	1.14%	1.10%	1.06%	0.98%	0.90%	1.08%	0.91%	1.00%

Inogen's average Quarter revenue forecast for Mar 24 based on 2 analysts is $73.66M, with a low forecast of $73.66M, and a high forecast of $73.67M. INGN's average Quarter revenue forecast represents a -2.94% decrease compared to the company's last Quarter revenue of $75.90M (Dec 23).

Inogen EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	1	3	1	2	2	4	2	2	2	1	1	1	1	2	2	2	2	13	8	8	9	12	7
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	$-28.98M	$-46.72M	$-7.46M	$-17.83M	$51.81M	$-10.29M	$2.97M	$-7.83M	$-906.00K	$11.90M	$16.91M	$2.97M	$-595.00K	$2.74M	$2.13M	$2.28M	$-703.00K	$11.77M
Avg Forecast	$-176.34K	$-210.44K	$-209.45K	$-176.11K	$-171.23K	$-193.57K	$-192.76K	$-165.87K	$-154.95K	$-176.48K	$-173.04K	$-10.29M	$-161.42K	$-173.22K	$-193.31K	$-8.14M	$-874.93K	$155.35K	$159.99K	$-6.43M	$120.79K	$137.82K	$141.09K	$4.61M	$110.70K	$120.92K	$127.11K	$3.78M	$137.37K	$145.71K
High Forecast	$-175.88K	$-209.89K	$-208.90K	$-175.65K	$-170.78K	$-193.06K	$-192.25K	$-165.43K	$-154.11K	$-176.47K	$-172.59K	$-8.23M	$-159.35K	$-172.70K	$-192.80K	$-6.51M	$-699.94K	$155.35K	$159.99K	$-5.15M	$120.79K	$137.82K	$141.09K	$5.53M	$110.70K	$120.92K	$127.11K	$4.54M	$137.37K	$145.71K
Low Forecast	$-176.86K	$-211.07K	$-210.07K	$-176.63K	$-171.73K	$-194.14K	$-193.33K	$-166.36K	$-156.00K	$-176.49K	$-173.56K	$-12.35M	$-163.51K	$-173.74K	$-193.88K	$-9.76M	$-1.05M	$155.35K	$159.99K	$-7.72M	$120.79K	$137.82K	$141.09K	$3.69M	$110.70K	$120.92K	$127.11K	$3.03M	$137.37K	$145.71K
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	179.55%	269.72%	38.59%	2.19%	-59.22%	-66.25%	18.58%	1.22%	-7.50%	86.32%	119.87%	0.64%	-5.37%	22.65%	16.75%	0.60%	-5.12%	80.77%

2 analysts predict INGN's average Quarter EBITDA for Mar 23 to be $-8.14M, with a high of $-6.51M and a low of $-9.76M. This is -115.70% lower than Inogen's previous annual EBITDA (Dec 22) of $51.81M.

Inogen Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	1	3	1	2	2	4	2	2	2	1	1	1	1	2	2	2	2	13	8	8	9	12	7
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	$-26.55M	$-45.72M	$-9.83M	$-20.35M	$-56.61M	$-9.51M	$-3.44M	$-14.21M	$-22.88M	$12.17M	$5.10M	$-732.00K	$-5.12M	$-1.70M	$2.58M	$-1.59M	$-1.38M	$6.86M
Avg Forecast	$-11.30M	$-5.36M	$-5.38M	$-11.55M	$-10.69M	$-7.36M	$-7.72M	$-11.40M	$-13.95M	$-11.77M	$-11.02M	$-17.84M	$-14.86M	$-28.82M	$-14.11M	$-14.10M	$-17.84M	$-9.92M	$-8.74M	$-11.15M	$-17.19M	$-5.90M	$-2.60M	$-1.24M	$-6.30M	$425.07K	$-1.81M	$-2.17M	$2.44M	$5.47M
High Forecast	$-11.26M	$-5.34M	$-5.36M	$-11.52M	$-10.65M	$-7.34M	$-7.69M	$-11.36M	$-12.97M	$-11.73M	$-10.99M	$-14.27M	$-13.03M	$-28.72M	$-14.06M	$-11.28M	$-14.27M	$-9.92M	$-8.74M	$-8.92M	$-17.19M	$-5.90M	$-2.60M	$-995.52K	$-6.30M	$425.07K	$-1.81M	$-1.73M	$2.44M	$5.47M
Low Forecast	$-11.34M	$-5.38M	$-5.40M	$-11.60M	$-10.73M	$-7.39M	$-7.75M	$-11.44M	$-15.42M	$-11.82M	$-11.07M	$-21.41M	$-16.23M	$-28.93M	$-14.16M	$-16.92M	$-21.41M	$-9.92M	$-8.74M	$-13.38M	$-17.19M	$-5.90M	$-2.60M	$-1.49M	$-6.30M	$425.07K	$-1.81M	$-2.60M	$2.44M	$5.47M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.79%	1.59%	0.70%	1.44%	3.17%	0.96%	0.39%	1.28%	1.33%	-2.06%	-1.96%	0.59%	0.81%	-4.00%	-1.43%	0.73%	-0.56%	1.25%

Inogen's average Quarter net income forecast for Dec 21 is $-17.19M, with a range of $-17.19M to $-17.19M. INGN's average Quarter net income forecast represents a -241.22% decrease compared to the company's last Quarter net income of $12.17M (Sep 21).

Inogen SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	1	3	1	2	2	4	2	2	2	1	1	1	1	2	2	2	2	13	8	8	9	12	7
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	$50.43M	$43.10M	$41.52M	$47.30M	$29.86M	$48.51M	$43.07M	$43.23M	$40.58M	$37.56M	$34.54M	$37.99M	$35.91M	$31.47M	$31.81M	$36.94M	$35.62M	$32.57M
Avg Forecast	$38.18M	$45.56M	$45.35M	$38.13M	$37.07M	$41.91M	$41.73M	$35.91M	$33.55M	$38.21M	$37.46M	$54.25M	$34.95M	$37.50M	$41.85M	$42.89M	$31.64M	$43.62M	$44.93M	$33.90M	$33.92M	$38.70M	$39.62M	$64.58M	$31.09M	$33.96M	$35.70M	$50.37M	$38.58M	$40.92M
High Forecast	$38.29M	$45.69M	$45.48M	$38.24M	$37.18M	$42.03M	$41.86M	$36.02M	$33.77M	$38.21M	$37.57M	$65.11M	$35.40M	$37.61M	$41.97M	$51.47M	$37.97M	$43.62M	$44.93M	$40.69M	$33.92M	$38.70M	$39.62M	$77.50M	$31.09M	$33.96M	$35.70M	$60.45M	$38.58M	$40.92M
Low Forecast	$38.08M	$45.44M	$45.23M	$38.03M	$36.97M	$41.80M	$41.62M	$35.82M	$33.37M	$38.21M	$37.36M	$43.40M	$34.50M	$37.39M	$41.74M	$34.31M	$25.31M	$43.62M	$44.93M	$27.12M	$33.92M	$38.70M	$39.62M	$51.67M	$31.09M	$33.96M	$35.70M	$40.30M	$38.58M	$40.92M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.44%	1.15%	0.99%	1.10%	0.94%	1.11%	0.96%	1.28%	1.20%	0.97%	0.87%	0.59%	1.16%	0.93%	0.89%	0.73%	0.92%	0.80%

Inogen's average Quarter SG&A projection for Mar 24 is $54.25M, based on 2 Wall Street analysts, with a range of $43.40M to $65.11M. The forecast indicates a 7.59% rise compared to INGN last annual SG&A of $50.43M (Dec 23).

Inogen EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	1	3	1	2	2	4	2	2	2	1	1	1	1	2	2	2	2	13	8	8	9	12	7
EPS	-	-	-	-	-	-	-	-	-	-	-	-	$-0.00	$-1.97	$-0.42	$-0.88	$-2.47	$-0.42	$-0.15	$-0.62	$-1.01	$0.54	$0.23	$-0.03	$-0.23	$-0.08	$0.12	$-0.07	$-0.06	$0.31
Avg Forecast	$-0.48	$-0.23	$-0.23	$-0.49	$-0.45	$-0.31	$-0.33	$-0.48	$-0.59	$-0.50	$-0.46	$-0.76	$-0.63	$-1.21	$-0.59	$-0.78	$-0.57	$-0.42	$-0.37	$-0.47	$-0.73	$-0.25	$-0.11	$-0.27	$-0.27	$0.02	$-0.08	$-0.11	$0.10	$0.23
High Forecast	$-0.47	$-0.22	$-0.23	$-0.48	$-0.45	$-0.31	$-0.32	$-0.48	$-0.55	$-0.49	$-0.46	$-0.75	$-0.55	$-1.21	$-0.59	$-0.78	$-0.57	$-0.42	$-0.37	$-0.47	$-0.73	$-0.25	$-0.11	$-0.27	$-0.27	$0.02	$-0.08	$-0.11	$0.10	$0.23
Low Forecast	$-0.48	$-0.23	$-0.23	$-0.49	$-0.45	$-0.31	$-0.33	$-0.48	$-0.65	$-0.50	$-0.47	$-0.76	$-0.68	$-1.22	$-0.60	$-0.78	$-0.58	$-0.42	$-0.37	$-0.47	$-0.73	$-0.25	$-0.11	$-0.27	$-0.27	$0.02	$-0.08	$-0.11	$0.10	$0.23
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.00%	1.62%	0.71%	1.13%	4.30%	1.00%	0.41%	1.31%	1.39%	-2.16%	-2.09%	0.12%	0.86%	-4.29%	-1.57%	0.65%	-0.61%	1.34%

According to 2 Wall Street analysts, Inogen's projected average Quarter EPS for Dec 21 is $-0.73, with a low estimate of $-0.73 and a high estimate of $-0.73. This represents a -234.81% decrease compared to INGN previous annual EPS of $0.54 (Sep 21).

Inogen Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
APYX	Apyx Medical	$1.42	$8.50	498.59%	Buy
INGN	Inogen	$9.21	$26.00	182.30%	Buy
SGHT	Sight Sciences	$3.76	$9.00	139.36%	Hold
LUNG	Pulmonx	$6.42	$11.93	85.83%	Buy
SIBN	SI-BONE	$12.29	$20.00	62.73%	Buy
KIDS	OrthoPediatrics	$26.47	$39.60	49.60%	Buy
NPCE	NeuroPace	$9.00	$12.88	43.11%	Buy
CNMD	CONMED	$71.71	$96.00	33.87%	Buy
OFIX	Orthofix Medical	$18.68	$24.00	28.48%	-
CVRX	CVRx	$14.77	$16.33	10.56%	Buy
AORT	Artivion	$28.03	$30.60	9.17%	Buy
ITGR	Integer	$135.88	$138.00	1.56%	Buy
SRDX	Surmodics	$39.19	$39.50	0.79%	Buy

INGN Forecast FAQ

Is Inogen a good buy?

Yes, according to 2 Wall Street analysts, Inogen (INGN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 50.00% of INGN's total ratings.

What is INGN's price target?

Inogen (INGN) average price target is $26 with a range of $26 to $26, implying a 182.30% from its last price of $9.21. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Inogen stock go up soon?

According to Wall Street analysts' prediction for INGN stock, the company can go up by 182.30% (from the last price of $9.21 to the average price target of $26), up by 182.30% based on the highest stock price target, and up by 182.30% based on the lowest stock price target.

Can Inogen stock reach $14?

INGN's average twelve months analyst stock price target of $26 supports the claim that Inogen can reach $14 in the near future.

What are Inogen's analysts' financial forecasts?

Inogen's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $344.9M (high $345.92M, low $343.99M), average EBITDA is $-723K (high $-722K, low $-726K), average net income is $-37.171M (high $-37.044M, low $-37.314M), average SG&A $156.62M (high $157.08M, low $156.21M), and average EPS is $-1.565 (high $-1.56, low $-1.571). INGN's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $368.22M (high $369.31M, low $367.25M), average EBITDA is $-772K (high $-770K, low $-775K), average net income is $-33.596M (high $-33.481M, low $-33.725M), average SG&A $167.21M (high $167.7M, low $166.77M), and average EPS is $-1.415 (high $-1.41, low $-1.42).

Did the INGN's actual financial results beat the analysts' financial forecasts?

Based on Inogen's last annual report (Dec 2023), the company's revenue was $315.66M, which missed the average analysts forecast of $326.32M by -3.27%. Apple's EBITDA was $-109M, beating the average prediction of $-8.665M by 1162.44%. The company's net income was $-102M, beating the average estimation of $-71.894M by 42.50%. Apple's SG&A was $182.35M, beating the average forecast of $157.19M by 16.01%. Lastly, the company's EPS was $-0.0044, missing the average prediction of $-3.213 by -99.86%. In terms of the last quarterly report (Dec 2023), Inogen's revenue was $75.9M, missing the average analysts' forecast of $76.96M by -1.38%. The company's EBITDA was $-28.982M, beating the average prediction of $-161K by 17854.52%. Inogen's net income was $-26.555M, beating the average estimation of $-14.861M by 78.69%. The company's SG&A was $50.43M, beating the average forecast of $34.95M by 44.29%. Lastly, the company's EPS was $-0.0011, missing the average prediction of $-0.626 by -99.82%